Leaflet GRANEGIS 2mg film-coated tablets

Product code:
W54807001
Quantity:
5
Indicated for:
chemotherapy-induced nausea and vomiting
Route of administration:
oral
Substance:
granisetron (antiemetic)
ATC
A04AA02 — Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Serotonin (5ht3) antagonists
Granisetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It belongs to a class of drugs known as 5-HT3 receptor antagonists.

This medication works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. It is available in tablet form, transdermal patches, or injectable solutions.

Granisetron is generally well-tolerated but may cause side effects such as headaches, constipation, or dizziness. In rare cases, severe allergic reactions may occur.

It is important to use granisetron as directed by your doctor and to inform medical staff about any other medications you are taking to avoid interactions.

General data about GRANEGIS 2mg

Substance:
granisetron
Date of latest medicines list:
01-07-2013
Product code:
W54807001
Concentration:
2mg
Pharmaceutical form:
film-coated tablets
Quantity:
5
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ACTAVIS HF. - ISLANDA
Holder:
EGIS PHARMACEUTICALS PLC - UNGARIA
Number:
4307/2012/01
Shelf life:
3 years

Concentrations available for granisetron

  • 1mg
  • 1mg/1ml
  • 1mg/ml
  • 20mcg/ml
  • 2mg
  • 3.1mg/24h
  • 3mg/3ml